相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
ETC-206
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1464151-33-4
- 规格:
1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 1 mg | 产品价格: | ¥478.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥1147.0 |
| 规格: | 10 mg | 产品价格: | ¥1763.0 |
| 规格: | 25 mg | 产品价格: | ¥2938.0 |
| 规格: | 50 mg | 产品价格: | ¥4288.0 |
| 规格: | 100 mg | 产品价格: | ¥5975.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Tinodasertib
CAS No. : 1464151-33-4
MCE 国际站:Tinodasertib
产品活性:Tinodasertib (ETC-206) 是一种选择性 MNK1 和 MNK2 抑制剂,IC50 分别为 64 nM 和 86 nM。
研究领域:MAPK/ERK Pathway
作用靶点:MNK
In Vitro: Tinodasertib (ETC-206) inhibits eIF4E phosphorylation in HeLa cell line with an IC50 of 321 nM. The anti-proliferative effects of ETC-206 are assessed in vitro, using CellTiter-Glo viability assay against 25 hematological cancer cell lines including the K562 cell line that overexpresses eIF4E (K562 o/e eIF4E). The IC50s are 1.71 μM, 3.36 μM, 3.70 μM, 4.81 μM, 5.13 μM, 5.05 μM, 6.70 μM, 9.76 μM, and 48.8 μM for SU-DHL-6, GK-5, MC 116, P3HR-1, DOHH2, MPC-11, Ramos.2G6.4C10, AHH-1, and K562 o/e eIF4E cells, respectively.
In Vivo: The antitumor effect of ETC-206 is then assessed in a K562 e/o eIF4E mouse xenograft model after oral administration at 25, 50, or 100 mg/kg alone or in combination with a 2.5 mg/kg fixed dose of Dasatinib throughout the study. Dasatinib at 2.5 mg/kg elicits a tumor growth inhibition (TGI) of 88% with one tumor-free animal. In contrast, ETC-206 alone only yields a maximum TGI of 23% at the highest administered dose of 100 mg/kg, which does not impede tumor growth, and is similar to the nontreated animals. ETC-206 with 2.5 mg/kg of Dasatinib not only increases tumor growth inhibition in a dose-dependent manner but, more importantly leads to 2, 5, and 8 out of 8 tumor-free animals at 25, 50, and 100 mg/kg, respectively. The combination of ETC-206 and Dasatinib inhibits tumor growth at all tested doses, and no weight loss is recorded. Both the combination of ETC-206 and Dasatinib and, on the other hand, the dual MNK1/2 and BCR-ABL1 inhibitors prevent tumor growth in the same mouse xenograft model. ETC-206 has moderate terminal elimination half-life (t1/2=1.7 h, and 1.77 h for mouse (1 mg/kg, i.v.), mouse (5 mg/kg, p.o.)).
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | Anti-Cancer Compound Library | Oxygen Sensing Compound Library | Anti-Obesity Compound Library | Targeted Diversity Library | Highly Selective Inhibitors Library | Serine/Threonine Kinase Inhibitor Library | Tomivosertib | HG-10-102-01 | CGP 57380 | SLV-2436 | Cercosporamide | DS12881479 | MNK1/2-IN-5 | EB1 | K783-0308 | MNK inhibitor 9 | MNK1/2-IN-6 | QL-X-138
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















